Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2001
10/04/2001WO2001072707A2 Carbamate caspase inhibitors and uses thereof
10/04/2001WO2001072703A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
10/04/2001WO2001072702A2 Amidino compounds useful as nitric oxide synthase inhibitors
10/04/2001WO2001072701A1 Ceramide derivatives and method of use
10/04/2001WO2001072699A1 Inhibition of angiogenesis and tumor growth
10/04/2001WO2001072680A1 Substituted chalcones as therapeutic compounds
10/04/2001WO2001072669A2 Therapeutic use of polyhydroxy amine derivates
10/04/2001WO2001072328A2 Methods of treating diseases with activated protein c
10/04/2001WO2001072325A1 Methods of blocking tissue destruction by autoreactive t cells
10/04/2001WO2001072323A2 Use of insulin for the treatment of cartilagenous disorders
10/04/2001WO2001072322A2 High dosage parenteral administration of lactoferrin
10/04/2001WO2001072305A1 A medicament and method for the production thereof
10/04/2001WO2001072297A1 Methods for inhibiting angiogenesis and tumor growth
10/04/2001WO2001072296A1 Method of inhibiting the expression of inflammatory cytokines and chemokines
10/04/2001WO2001072290A2 Method for the improvement of islet signaling in diabetes mellitus and for its prevention
10/04/2001WO2001072281A2 Microspheres for active embolization
10/04/2001WO2001072279A2 Medical emulsion for lubrication and delivery of drugs
10/04/2001WO2001049688A8 Purine derivatives, process for their preparation and use thereof
10/04/2001WO2001047878A8 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/04/2001WO2001036638A8 Polypeptides and nucleic acids encoding same
10/04/2001WO2001022990A3 Methods related to immunostimulatory nucleic acid-induced interferon
10/04/2001WO2001022959A3 Compositions comprising progesterone or progesterone analogs for the treatment of inflammatory conditions
10/04/2001WO2001021784A3 Pcna-associated cell cycle proteins, compositions and methods of use
10/04/2001WO2001019828A3 Kinase inhibitors as therapeutic agents
10/04/2001WO2001019361A3 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
10/04/2001WO2001016319A3 Compositions and methods for the treatment of immune related diseases
10/04/2001WO2001013957A3 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
10/04/2001WO2000062795A9 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS
10/04/2001WO2000047625A9 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
10/04/2001WO2000032634A9 Humanized antibodies to gamma-interferon
10/04/2001US20010027212 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
10/04/2001US20010027207 Modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation; anticarcinogenic, -diabetic, -proliferative and -inflammatory agents; vascular system disorders
10/04/2001US20010027197 Antiproliverative, -carcinogenic and -tumor agents; mitogenesis-activated protein kinase inhibitors; noncytotoxic; binding with high affinity at the adenosine triphosphate binding site of the kinases
10/04/2001US20010027184 Serine/threonine protein kinase (H-SGK2)
10/04/2001US20010026794 Two heterologous DNA encoding gene products; prolonged half-life
10/04/2001EP1138692A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator
10/04/2001EP1138680A1 Gem substituted sulfonyl hydroxamic acids as MMP inhibitors
10/04/2001EP1137806A1 Detection of rantes gene promoter polymorphisms
10/04/2001EP1137773A2 Growth factor homolog zvegf3
10/04/2001EP1137658A1 METHODS OF MODULATING TUMOR NECROSIS FACTOR $g(a)-INDUCED EXPRESSION OF CELL ADHESION MOLECULES
10/04/2001EP1137656A1 31 human secreted proteins
10/04/2001EP1137640A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
10/04/2001EP1137439A2 Stabilization of macrolides
10/04/2001EP1137438A1 Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors
10/04/2001EP1137429A2 Bioflavonoids, anthocyanins and phenolic compounds from cherries for inhibiting inflammation
10/04/2001EP1137415A1 Myt1 kinase inhibitors
10/04/2001EP1137410A1 Novel 4-dedimethy laminotetra cycline derivatives
10/04/2001EP1079852B1 Composition based on pentoxifylline and anticytokin
10/04/2001EP0950408B1 Oily patches for external use containing diclofenac sodium
10/04/2001EP0891326B1 Novel vitamin d analogues
10/04/2001EP0880528B1 Spiro-ketal derivatives and their use as therapeutic agents
10/04/2001EP0874841B1 1-benzenesulfonyl pyrrolidine derivatives as bradykinin receptor antagonists
10/04/2001EP0828726B1 Tricyclic inhibitors of matrix metalloproteinases
10/04/2001EP0809635B1 Alpha-substituted hydrazides having calpain inhibitory activity
10/04/2001EP0639979B1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
10/04/2001DE19947154A1 Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
10/04/2001CA2659030A1 Methods for inhibiting angiogenesis and tumor growth
10/04/2001CA2404964A1 Methods for detecting inflammation and inflammatory conditions
10/04/2001CA2404669A1 Condensed pyrazole derivatives, process for producing the same and use thereof
10/04/2001CA2404662A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001CA2404626A1 Novel piperazine derivatives
10/04/2001CA2404532A1 Method of identifying inhibitors of tie-2
10/04/2001CA2404495A1 Human tap-like protein (transporter associated in antigen processing/presentation)
10/04/2001CA2404448A1 Genes involved in intestinal inflammatory diseases and use thereof
10/04/2001CA2404445A1 Tricyclic protein kinase inhibitors
10/04/2001CA2404231A1 Methods of treating diseases with activated protein c
10/04/2001CA2403906A1 Pharmaceutical compositions containing oligosaccharides and preparation thereof
10/04/2001CA2403857A1 Anti-angiogenic and anti-tumor properties of matin and other laminin domains
10/04/2001CA2403800A1 Beta-like glycoprotein hormone polypeptide and heterodimer
10/04/2001CA2403787A1 Il-8 receptor antagonists
10/04/2001CA2402769A1 Ceramide derivatives and method of use
10/04/2001CA2402735A1 Human transcription factors
10/04/2001CA2401748A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders
10/04/2001CA2401249A1 Use of cd25 binding molecules in the treatment of inflammatory diseases of the gastro-intestinal tract
10/04/2001CA2399864A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
10/04/2001CA2374911A1 G-protein coupled receptors
10/03/2001CN1315942A 2-oxo-j(2H)-quinoline derivatives
10/03/2001CN1315866A Method of modulating memory effector T-cells using CD2-binding agent, and compositions
10/03/2001CN1315863A Use of rosmarinic acid and derivatives thereof as immunosuppressant or inhibitor of SHz-mediated process
10/03/2001CN1315856A Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
10/03/2001CN1315852A Medicinal aerosol formulations
10/03/2001CN1315187A Compound and liquid for relieving inflammation and pain
10/03/2001CN1315178A Compound sodium salicylate tablet
10/03/2001CN1072220C 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derives as neurokinin receptor antagonists
10/02/2001US6297399 Hypotensive agents
10/02/2001US6297381 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor, ureas or thioureas substituted by a pyrrole or thiophene
10/02/2001US6297375 4-phenyl-pyridine derivatives
10/02/2001US6297282 Substituted derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase II
10/02/2001US6297281 Association of no syntase inhibitors with trappers of oxygen reactive forms
10/02/2001US6297277 Cysteine protease inhibitors containing heterocyclic leaving groups
10/02/2001US6297264 E.g., 4-(2-benzyloxy-2-(3-cyclopentyloxy-4-methoxyphenyl)ethyl)pyrid ine; phosphodiesterase inhibitors
10/02/2001US6297261 Potent chloride channel blockers; treatment of sickle cell anemia, brain edema following ischaemia or tumors, diarrhea, hypertension (diuretic), osteoporosis, and for the reduction of the intraocular pressure
10/02/2001US6297260 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/02/2001US6297257 Benzazine derivatives phosphodiesterase 4 inhibitors
10/02/2001US6297238 3-aryl pyrazoles with 4,5(3,4)-bicyclic ring fusion which are inhibitors of protein kinases particularly tyrosine kinases and serine/threonine kinases
10/02/2001US6297217 Boronic ester and acid compounds, synthesis and uses
10/02/2001US6297036 YAK-1 related serine/threonine protein kinase-HTLAR33
10/02/2001US6297022 Method of identifying agonists and antagonists for tumor necrosis related receptor TR1
10/02/2001CA2078000C Neutrophil stimulating peptides
10/02/2001CA2041268C Peptides with a bradykinin-antagonistic action
1 ... 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 ... 1272